STI Testing Methods: Antigen vs. Antibody Detection
STI testing uses BOTH antigen and antibody detection methods, depending on the specific pathogen being tested—the choice is pathogen-specific, not a single universal approach.
Testing Strategy by Pathogen Type
Antibody-Based Testing
Syphilis is diagnosed primarily through antibody detection using a two-step approach 1:
- Treponemal-specific antibody tests (EIA/chemiluminescence immunoassay) are used first in the reverse screening algorithm
- Nontreponemal antibody tests (RPR - rapid plasma reagin) follow for confirmation
- Both test types detect antibodies, not antigens, because Treponema pallidum cannot be cultured in routine laboratories 1
HIV and Hepatitis C screening relies on antibody detection 1:
- HIV screening should occur in each new pregnancy and in sexually active patients aged 13-64 seeking STI evaluation
- Important caveat: HIV self-tests available in Germany only detect antibodies, meaning a negative result is only reliable 12 weeks after exposure 2
Herpes simplex virus type 2 (HSV-2) uses antibody-based immunosorbent assays targeting glycoprotein G-2 3
Antigen and Nucleic Acid Detection
Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis are optimally detected through direct pathogen identification 1:
- Nucleic acid amplification tests (NAATs) are the preferred method for these pathogens
- Testing simultaneously for CT, GC, and Trichomonas is optimal for detecting the most common treatable STIs in female patients 1
- For Trichomonas specifically, transcription-mediated amplification (TMA) shows 98.4% sensitivity, while rapid antigen testing shows 82% sensitivity—both far superior to wet mount at 50.8% 4
Bacterial vaginosis and vulvovaginal candidiasis use direct detection methods 1:
- Gram stain for bacterial vaginosis (detects organisms directly, not antibodies)
- Microscopy with KOH for yeast (direct visualization)
- Culture when needed
Key Clinical Considerations
High-Risk Population Testing
- MSM and other high-risk individuals should have extragenital sites evaluated (rectal, oropharyngeal) for GC and CT using NAATs 1
- These require direct pathogen detection, not antibody testing
Common Pitfall
The sensitivity and specificity of point-of-care tests vary widely 1. While rapid antigen tests exist for some STIs, molecular diagnostics (NAATs) are the preferred test type when available, especially in asymptomatic patients 5. For syphilis, point-of-care antibody tests still require subsequent laboratory confirmation 2.
Pregnancy Screening
- Syphilis: antibody testing three times during pregnancy 6
- Group B Streptococcus: culture-based detection (direct pathogen identification) at 35-37 weeks using vaginal and rectal swabs 1
The fundamental principle: Bacterial and parasitic STIs (chlamydia, gonorrhea, trichomonas) use antigen/nucleic acid detection for active infection, while syphilis and viral STIs (HIV, HSV) primarily use antibody detection because these pathogens cannot be easily cultured or are best diagnosed serologically 7, 5.